study

(redirected from Open-label study)
Also found in: Dictionary, Thesaurus, Medical, Legal.
Related to Open-label study: Prospective study, Double blind study

study

1. a drawing, sculpture, etc., executed for practice or in preparation for another work
2. a musical composition intended to develop one aspect of performing technique
3. Theatre a person who memorizes a part in the manner specified

study

A drawing executed as an educational exercise, produced as a preliminary to a final work or made record observations.
See also: Design drawing

study

1. A room or alcove of a house or apartment used primarily as a place for reading, writing, and study. It often embodies the features of a private office and private library.
2. A preliminary sketch or drawing to facilitate the development of a design.
References in periodicals archive ?
Another group of investigators conducted a 6-month open-label study of 541 patients diagnosed with a bipolar disorder (66.
The open-label study was an extension of three 8-week placebo-controlled trials that demonstrated escitalopram (Lexapro) to be effective in the short-term treatment of generalized anxiety disorder.
Yeager, Senior Vice President for Scientific Affairs commented, "The new Phase 3 open-label study is intended to confirm the safety of Alprox-TD(R) on a longer term basis.
Interim results from open-label study 26 are consistent with previous ATX-101 studies
After 8 weeks in an open-label study 12 of 15 patients responded and 8 remitted.
The program will be conducted in two stages beginning today with an open-label study in a select ALS patient population.
We look forward to finalizing data from this open-label study to provide physicians with more information about the use of ONFI for patients with a history of LGS who continue to have seizures due to the intractable nature of the disease.
The second phase of the study included a 4-month open-label study of 63 children who had previously been medicated with risperidone.
Patients maintained on Zenvia 30/10 mg demonstrated statistically significant incremental improvement in their CNS-LS scores over the additional 12-week treatment period of the open-label study (p<0.
In a prospective, open-label study of 79 patients who were delirious and hospitalized for various cancers, patients older than 70 years were 172 times more likely to have a significantly poorer response to olanzapine over 7 days of treatment (Psychosomatics 43[3]:175-82, 2002).